NEW YORK (GenomeWeb News) – BG Medicine said after the close of the market Friday that it has received notice from the Listing Qualifications Department of the Nasdaq Stock Market that it is not in compliance with one of the requirements for continued listing.

Specifically, Nasdaq said that the firm's market value of its listed securities had closed below the minimum $50 million required for continued listing for the 30 days leading up to Dec. 10. BG has until June 10, 2013, to regain compliance with the rule.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.